Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

NCT07353957 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer - Non Small Cell Squamous
Lung Cancer - Non Small Cell Non-Squamous

Interventions

COMBINATION_PRODUCT: Petosemtamab + Pembrolizumab

Sponsor

Merus B.V.